Peter Lichter

16PUBLICATIONS
187CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursBiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 28, 2026
Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer.

|Sep 24, 2026
Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency.

|Oct 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.

Mario Hlevnjak, Sabine Heublein, Verena Thewes

|Sep 16, 2024
SOX10 mediates glioblastoma cell-state plasticity.

Ka-Hou Man, Yonghe Wu, Zhenjiang Gao

|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta

|Jan 21, 2023
Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.

Lavinia Arseni, Rakesh Sharma, Norman Mack

Pageof 3

Frequent Collaborators

10 joint publications

Marc Zapatka

5 joint publications

Martina Seiffert

3 joint publications

Roland Eils

3 joint publications

Philipp M Roessner